Company
Trans Global Group, Inc.
Headquarters: Coconut Creek, FL, United States
CEO: Mr. Chen Ren
Market Cap
$13.5 Million
USD as of Jan. 1, 2024
Trans Global Group, Inc. Categories
United States Healthcare Drug Manufacturers—Specialty & GenericUnited States Healthcare United States Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Trans Global Group, Inc. focuses on effecting a merger or acquisition with an unidentified company. The company operates as an investment company that plans to acquire companies in the liquor industry in China. Previously, it was engaged in the general construction, and renewable and solar energy sector. The company is headquartered in Shenzhen, China.
Top 1-year algo backtest: +298.72%
$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Trans Global Group, Inc. has the following listings and related stock indices.
Stock: OTC: TGGI wb_incandescent